Agilent Technologies Acquires Kalabie Electronic Laboratory Notebook from Klee Group
News Jun 19, 2007
Agilent Technologies Inc. has announced it has acquired the Klee Group’s Kalabie Electronic Laboratory Notebook (ELN). The focus for this product, which is Agilent’s first electronic notebook, will be on the pharmaceutical market and some chemical applications. Financial details of the acquisition were not disclosed.
Kalabie ELN is a configurable software solution for the R&D sector, used by pharmaceutical and dermo-cosmetic companies since 2004 to boost productivity and enhance collaboration of chemistry and biology scientists.
A digital laboratory notebook, Kalabie ELN provides a foundation for knowledge and process management as well as intellectual property protection within laboratories. Kalabie ELN centralizes and secures all data from experimental work with a high level of traceability. Offering a rich package of features plus flexibility, Kalabie ELN can be deployed as a standard packaged solution or it can be configured to meet customers’ specific needs.
Agilent’s current portfolio of laboratory software includes OpenLAB -- the operating system for the laboratory. Agilent plans to integrate the Kalabie ELN product into OpenLAB in the next six months to provide customers with the ability to manage computing resources in the laboratory with a complete solution.
“With the addition of Kalabie, Agilent can provide customers with a complete software solution and a single-vendor approach to their laboratory management needs,” said Bruce von Herrmann, vice president and general manager for Agilent’s Software and Informatics Division. “ELNs simplify knowledge and data integration. The combined capabilities of Kalabie ELN, OpenLAB and GeneSpring provide unique capabilities that enhance productivity.”
“Integrating into Agilent’s software and informatics portfolio is exciting for the Kalabie ELN team,” said Alain Meller, Kalabie director at the Klee Group. “This will immediately provide our customers the benefits of Agilent’s global reach and support capabilities, allowing for rapid deployment of ELN solutions across organizations and geographies. Moreover, with the combined capabilities that Agilent OpenLAB offers, we will speed up our ability to market and deliver high-value, global, integrated lab informatics solutions where the ELN is a key component.”
Prior to its acquisition by Agilent, Kalabie was a division of Klee Group, an information system consulting firm founded in 1987.
Modified Form of Botox Could Replace Opioids as Treatment for Chronic PainNews
A modified form of botulinum toxin gives long-lasting pain relief in mice without adverse effects and, in time, could replace opioid drugs as a safe and effective way of treating chronic pain, according to new research.READ MORE
Key Ingredient in Diabetes Drug Modified to Improve Side EffectsNews
Improved medications for Type 2 diabetes are one step closer thanks to a new discovery reported this week. By modifying the key ingredient in current diabetes drugs, the researchers produced a compound that was effective for hyperglycemia in animal trials, yet without the most problematic side effects of current drugs.READ MORE
Tackling Cancer at Ground Zero: Designer Molecule Inhibits Protein TargetNews
A new molecule designed by University of Adelaide researchers shows great promise for future treatment of many cancers. The new molecule successfully targets a protein that plays a major role in the growth of most cancers.READ MORE